_parp-inhibitor-olaparib-slows-progression-of-advanced-prostate-cancer.jpg "PARP inhibitor olaparib slows progression of advanced prostate cancer from parp Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 5 min 38 sec
✓ Published: 30-Sep-2019
✓ Published: 30-Sep-2019
Description:
Prof Maha Hussain presents data from thePROfound trial during a press conference at the 2019 ESMO congress.nnThis was a trial evaluating the PARP inhibitor olaparib vs new hormonal agents in patients with metastatic, pre-treated prostate cancer whose cancer cells had faulty DNA repair genes.nnSign up to ecancer for free to receive tailored email alerts for more videos like this.necancer.org/account/register.php
Prof Maha Hussain presents data from thePROfound trial during a press conference at the 2019 ESMO congress.nnThis was a trial evaluating the PARP inhibitor olaparib vs new hormonal agents in patients with metastatic, pre-treated prostate cancer whose cancer cells had faulty DNA repair genes.nnSign up to ecancer for free to receive tailored email alerts for more videos like this.necancer.org/account/register.php
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_part-1-dna-damage-response-and-parp-inhibition.webp "Short chapter from the Mechanism of Action of PARP inhibitors and Targeting DNA Damage Response (DDR) video")
_immunomodulatory-effects-of-parp-inhibition-in-brca1-deficient-triple-negative-breast-cancer.webp "Dr Constantia Pantelidou speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about a study which looked at the immunomodulatory effects of PARP inhibition in BRCA1-deficient triple-negative breast cancer (TNBC).nnShe reports that PARP inhibitors induce an anti-tumour immune response in BRCA1-deficient TNBC but not in BRCA1-proficient TNBC.nnDr Pantelidou explains that this T cell recruitment is mediated through activation of the STING pathway and this activation")
⏲ 1 min 67 sec ✓ 09-Apr-2019
_asco-2022-latest-in-prostate-cancer-including-parp-inhibitors.webp "Dr Neal Shore (Carolina Urologic Research Center, Myrtle Beach, USA), Prof Phil Cornford (Royal Liverpool University Hospital, Liverpool, UK), Prof Eleni Efstathiou (Houston Methodist Cancer Center, Houston, USA) and Prof Cora Sternberg (Weill Cornell Medicine, New York, USA) discuss the latest in prostate cancer, including PARP inhibitors. nnInitially, they discuss the latest trials and updates in prostate cancer including PROPEL, MAGNITUDE and the ARCHES trial.nnThey discuss the use of Lutetiu")
_parp11.webp "PARP11 from parp")
_breast-cancer-treatment.webp "Animation showing a drug MOA for treating breast cancer.")
_parp-inhibitor-maintenance-therapy-for-pancreatic-cancer-with-brca-mutation.webp "At the 2019 Great Debates and Updates in GI Malignancies meeting, Eileen O'Reilly, MD, debated in favor of using PARP inhibitors as maintenance therapy for patients with BRCA mutation–positive pancreatic cancer.")
⏲ 1 min 51 sec ✓ 14-Sep-2019
_parp-inhibitors-and-their-evolving-role-for-the-treatment-of-prostate-cancer.webp "Drs Shore, Agarwal, Castro and Chi discuss the latest in PARP inhibitors in prostate cancer.nnStarting with some background on the science involved in PARP inhibition, they cover some of the major studies presented at ESMO 2020:nn- PROfoundn- TALAPRO-1n- KEYNOTE-365n- TRITON2n- NADIRnnThe panel discuss the science behind the studies and their potential impact on clinical practice from a global perspective.nnThey cover the increasing importance of testing, the differ")
⏲ 23 min 26 sec ✓ 24-Sep-2020
_parp-inspiracje-odblaski-124-darek-zatorski.webp "PARP - Inspiracje - Odblaskindir: Darek Zatorskinnprezentacja dorobku - creative showcasenpoint of you")
_part-1-dna-damage-response-and-parp-inhibition.jpg)
_immunomodulatory-effects-of-parp-inhibition-in-brca1-deficient-triple-negative-breast-cancer.jpg)
_asco-2022-latest-in-prostate-cancer-including-parp-inhibitors.jpg)
_parp11.jpg)
_breast-cancer-treatment.jpg)
_parp-inhibitor-maintenance-therapy-for-pancreatic-cancer-with-brca-mutation.jpg)
_parp-inhibitors-and-their-evolving-role-for-the-treatment-of-prostate-cancer.jpg)
_parp-inspiracje-odblaski-124-darek-zatorski.jpg)
![[+]](/images/menu.gif){kind=small}